LAURUSLABS.NS

Laurus Labs Limited · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$7.44B

PE Ratio

71.22

EV to Ebitda

—

Earnings Yield

1.00%

Revenue (TTM)

$712.5M

Net Income (TTM)

$104.4M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

6.00%

Profit Margin

13.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$7.44B

Revenue TTM$712.5M

Shares Outstanding539.9M

Float353938972

Insider Ownership32.00%

Institutional Ownership29.00%

Growth Estimates6 fields›

Revenue Growth (Quarterly YoY)6.00%

Rev Growth Est 1Y Forward0.14

EPS Growth (Quarterly YoY)19.00%

EPS Growth Est Quarterly4.98

LT EPS Growth Estimates18.00%

EBITDA Growth (Quarterly YoY)24.00%

Operations20 fields›

Revenue TTM$712.5M

Gross Margin TTM61.00%

Gross Margin (Quarterly)42.00%

Operating Margin TTM22.00%

Operating Margin (Quarterly)22.00%

Operating Expenses TTM$17.7M

Profit Margin TTM13.00%

Profit Margin (Quarterly)14.00%

Net Income TTM$104.4M

EPS TTM15.62

EPS (Quarterly)4.66

EBIT Margin TTM27.61%

EBITDA Margin TTM27.00%

EBITDA Margin (Quarterly)28.00%

EBITDA TTM$190.1M

CFO TTM$68.6M

Capex % of Revenue TTM16.00%

Capital Expenditures$117.2M

FCF % of Revenue (Quarterly)6.00%

FCF TTM$68.6M

Efficiency1 fields›

ROA9.00%

Valuation7 fields›

P/E (TTM)71.22

P/E Forward0

EV/Revenues (TTM)10.26

Price To Book13.52

Price to Tangible Book14.23

Earnings Yield1.00%

Payout Ratio12.00%

Liquidity7 fields›

Cash Per Share2.1

Current Ratio1.33

Goodwill & Intangibles$2647.00T

Total Assets$1.09B

Shareholders Equity$549.8M

Interest Expense$17.7M

Goodwill % of Assets2518269.00%

Yields3 fields›

Payout Ratio12.00%

Earnings Yield1.00%

Buyback Yield0.00%